awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q53103129-F271BD85-E69C-42AB-83C5-4ECF87FB6C07
Q53103129-F271BD85-E69C-42AB-83C5-4ECF87FB6C07
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53103129-F271BD85-E69C-42AB-83C5-4ECF87FB6C07
Health policy: Me-too drugs with limited benefits - the tale of regorafenib for HCC.
P2860
Q53103129-F271BD85-E69C-42AB-83C5-4ECF87FB6C07
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53103129-F271BD85-E69C-42AB-83C5-4ECF87FB6C07
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
279bee9ffc8c1f3cc9fb31ae01471f479d09e9ce
P2860
Determinants of survival after sorafenib failure in patients with BCLC-C hepatocellular carcinoma in real-world practice